Hologic shares remained relatively unmoved today on first-quarter results that fell shy of the Wall Street forecast.

Medical technology company Hologic (NASDAQ:HOLX) in Q4 CY2025 as sales rose 2.5% year on year to $1.05 billion. Its non-GAAP ...

Hologic (HOLX) came out with quarterly earnings of $1.04 per share, missing the Zacks Consensus Estimate of $1.09 per share.

Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Thursday after market hours. Here’s what you ...

The market awaits Hologic's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter. It's important for new investors to ...

MARLBOROUGH - Hologic, Inc. (NASDAQ:HOLX) reported fiscal first quarter earnings that fell short of analyst expectations, with revenue of $1.05 billion missing the consensus estimate of $1.07 billion.

Market attention is now squarely focused on February 5th, when a special shareholder meeting will be held. Investors will vote on a definitive merger agreement involving a consortium led by private ...

Event context and recent share performance Hologic (HOLX) has been drawing investor attention recently as its shares trade ...

Women’s health tech company Hologic is launching "Better is Possible," a new health education and awareness campaign aimed at getting women to talk to their doctors about their disruptive period ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today launched Project Health Equality (PHE), a unique initiative that strives to address the ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

Though the vast majority of women are aware of the importance of early screening for various cancers and other life-threatening health conditions, a new survey estimates that nearly half of those in ...